Statements and Interviews
28 July 2023 - Il Sole 24 Ore
Francesco De Santis (Confindustria): "Strengthen R&D credit to invest more"
Go to article
September 2023 - Enea - Energia Ambiene e Innovazione
Francesco De Santis (Confindustria): Research & Development are the winning recipe in all sectors
Go to article
21 September 2023 - Il Sole 24 Ore
Enterprise Award for Innovation (Interview with Dr. Francesco De Santis - Vice President Confindustria for R&D)
Go to article
03 November 2021 - Il Sole 24 Ore
De Santis: "Patent box strategico negli investimenti in Ricerca & Sviluppo"
Go to article
05 April 2021 - laDiscussione
Francesco De Santis (Confindustria): "Research and development change the tax credit"
Go to article
03 April 2021 - Il Sole 24 Ore
De Santis: "Vanno risolte le criticità del credito d'imposta per la ricerca"
Go to article
18 January 2021 - Corriere Economia
La resilienza del pharma. Un modello per tutta l'industria.
Go to article
February 2021 - Premio Imprese per Innovazione of Confindustria
Innovare per Candidarsi a Vincere! - Article for Entrapreneur (Statement of F. De Santis)
Go to article
11 December 2020 - Press Release Confindustria
CONFINDUSTRIA CONFERISCE IL “PREMIO IXI” A 12 IMPRESE TOP IN R&I (Statement of F. De Santis)
Read the Press Release
29/31 May 2019 - PHARMASTAR
Therapeutic Equivalence…
Video Interview Dr. Francesco De Santis
Watch the video interview on PHARMASTAR
22 July 2013 - AGIR
Italfarmaco, il settore ha bisogno di certezze per favorire programmazione e investimenti
Interview to Francesco De Santis, President of Italfarmaco and Vice-President of Farmindustria
Read the interview on PDF
12 February 2013 - Meeting & Congressi
Interview to Francesco De Santis, President of Italfarmaco and VicePresident of Farmindustria
Watch the video interview on MC Online
Read the interview on PDF
23 June 2012 - Pharmastar
Annual Meeting SIF
Interview to Dr. Francesco De Santis, President of Italfarmaco and Vice President of Farmindustria
View the interview on YouTube
July 2009 - Focus Reports
Italy: Towards Pharmaceutical Renaissance, Part 1
"...Whereas Italfarmaco’s main driver is research”, Francesco De Santis afferma, “the second one is surely international expansion. A consistent share of the revenues generated is reinvested to fulfil global ambitions and conquer new markets...."
Read the full statement on the website of Focus Reports
April 2009 - Focus Reports
Intervista a Francesco De Santis, Presidente Italfarmaco Holding
"A number of success factors, that are inherent to Italfarmaco’s identity, have allowed the company to maintain its growth in the past 10 years. First of all, it is a family company- therefore submitted to financial constraints, but on the other hand able to establish long-term plans without being affected by the market’s ups and downs. In addition, Italfarmaco always remained committed to research and innovation..."
Read the interview on the website of Focus Reports
Read the interview in PDF format (800 KB)
Curriculum of Francesco De Santis on Focus Reports website